This is the old version of SRDR. The next, SRDRplus is available! Registration of your SRDRPlus account is free and approval is automatic. Click Here to register an SRDRPlus account.

Advanced Search

Project: Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Systematic Review of Perinatal Pharmacological Interventions

Public Report Complete

Project Summary

Title and Description

Key Questions

Associated Extraction Forms

Title Created by Key Questions Addressed Form Notes
Extraction Form Bryant Smith 1, 2, 3, 4

Associated Studies (each link opens a new tab)

Title Author Year
A placebo controlled treatment trial of sertraline and interpersonal psychotherapy for postpartum depression. O'Hara MW., Pearlstein T., Stuart S., Long JD., Mills JA., Zlotnick C. 2019
The Relationship Between Pregnancy Exposure to Antidepressant and Atypical Antipsychotic Medications and Placental Weight and Birth Weight Ratio: A Retrospective Cohort Study. Frayne J., Nguyen T., Hauck Y., Liira H., Keelan JA. 2018
Neonatal outcomes in pregnant women with untreated and treated panic disorder. Uguz F., Yuksel G., Onur OS., Karsidag C., Gezginc K., Arpaci N. 2018
Alterations in Resting-State Networks Following In Utero Selective Serotonin Reuptake Inhibitor Exposure in the Neonatal Brain. Rotem-Kohavi N., Williams LJ., Virji-Babul N., Bjornson BH., Brain U., Werker JF., Grunau RE., Miller SP., Oberlander TF. 2019
Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. Meltzer-Brody S., Colquhoun H., Riesenberg R., Epperson CN., Deligiannidis KM., Rubinow DR., Li H., Sankoh AJ., Clemson C., Schacterle A., Jonas J., Kanes S. 2018
The use of antidepressant drugs in pregnant women with epilepsy: A study from the Australian Pregnancy Register. Sivathamboo N., Hitchcock A., Graham J., Sivathamboo S., Chen Z., O'Brien TJ., Vajda FJE. 2018
Risk of Major Malformations in Infants Following First-Trimester Exposure to Quetiapine. Cohen LS., Góez-Mogollón L., Sosinsky AZ., Savella GM., Viguera AC., Chitayat D., Hernández-Díaz S., Freeman MP. 2018
Reproductive Safety of Second-Generation Antipsychotics: Current Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. Cohen LS., Viguera AC., McInerney KA., Freeman MP., Sosinsky AZ., Moustafa D., Marfurt SP., Kwiatkowski MA., Murphy SK., Farrell AM., Chitayat D., Hernández-Díaz S. 2016
Major depressive disorder during pregnancy: Psychiatric medications have minimal effects on the fetus and infant yet development is compromised. Gustafsson HC., Goodman SH., Feng T., Choi J., Lee S., Newport DJ., Knight B., Pingeton B., Stowe ZN., Monk C. 2018
Comparison of two different treatments in depressed pregnant women: fetal growth characteristics and neonatal outcomes. Giardinelli L., Lelli L., Ugolini V., Lazzeretti L., Burian I., Lino G., Lunardi C., Castellini G., Ricca V. 2018
Obstetrical and neonatal outcomes after benzodiazepine exposure during pregnancy: Results from a prospective registry of women with psychiatric disorders. Freeman MP., Góez-Mogollón L., McInerney KA., Davies AC., Church TR., Sosinsky AZ., Noe OB., Viguera AC., Cohen LS. -- Not Found --
Aripiprazole and pregnancy: A retrospective, multicentre study. Galbally M., Frayne J., Watson SJ., Snellen M. 2018
Antidepressants and recurrence of depression in the postpartum period. Pope CJ., Sharma V., Sommerdyk C., Mazmanian D. 2018
Self-reported perinatal depressive symptoms and postnatal symptom severity after treatment with antidepressants in pregnancy: a cross-sectional study across 12 European countries using the Edinburgh Postnatal Depression Scale. Lupattelli A., Twigg MJ., Zagorodnikova K., Moretti ME., Drozd M., Panchaud A., Rieutord A., Juraski RG., Odalovic M., Kennedy D., Rudolf G., Juch H., Nordeng H. 2018
Effect of Time-Dependent Selective Serotonin Reuptake Inhibitor Antidepressants During Pregnancy on Behavioral, Emotional, and Social Development in Preschool-Aged Children. Lupattelli A., Wood M., Ystrom E., Skurtveit S., Handal M., Nordeng H. 2018
Maternal mood disorders and lithium exposure in utero were not associated with poor cognitive development during childhood. Forsberg L., Adler M., Römer Ek I., Ljungdahl M., Navér L., Gustafsson LL., Berglund G., Chotigasatien A., Hammar U., Böhm B., Wide K. 2018
Gestational Weight Gain and Pre-pregnancy Body Mass Index Associated With Second-Generation Antipsychotic Drug Use During Pregnancy. Freeman MP., Sosinsky AZ., Goez-Mogollon L., Savella GM., Moustafa D., Viguera AC., Cohen LS. -- Not Found --
Antidepressant Use in Late Gestation and Breastfeeding Rates at Discharge from Hospital. Leggett C., Costi L., Morrison JL., Clifton VL., Grzeskowiak LE. 2017
Antidepressant use during pregnancy and psychiatric disorders in offspring: Danish nationwide register based cohort study. Liu X., Agerbo E., Ingstrup KG., Musliner K., Meltzer-Brody S., Bergink V., Munk-Olsen T. 2017
Risk of preeclampsia after gestational exposure to selective serotonin reuptake inhibitors and other antidepressants: A study from The Norwegian Mother and Child Cohort Study. Lupattelli A., Wood M., Lapane K., Spigset O., Nordeng H. 2017
Use of atypical antipsychotics in pregnancy and maternal gestational diabetes. Panchaud A., Hernandez-Diaz S., Freeman MP., Viguera AC., MacDonald SC., Sosinsky AZ., Cohen LS. 2017
Antidepressants during pregnancy and autism in offspring: population based cohort study. Rai D., Lee BK., Dalman C., Newschaffer C., Lewis G., Magnusson C. 2017
Association of Antidepressant Medication Use During Pregnancy With Intellectual Disability in Offspring. Viktorin A., Uher R., Kolevzon A., Reichenberg A., Levine SZ., Sandin S. 2017
Mood symptoms in pregnant and postpartum women with bipolar disorder: a naturalistic study. Driscoll KE., Sit DKY., Moses-Kolko EL., Pinheiro E., Yang A., Ciolino JD., Eng HF., Luther JF., Clark CT., Wisniewski SR., Wisner KL. 2017
Antidepressant Use in Pregnancy and the Risk of Attention Deficit with or without Hyperactivity Disorder in Children. Boukhris T., Sheehy O., Bérard A. 2017
Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. Kanes S., Colquhoun H., Gunduz-Bruce H., Raines S., Arnold R., Schacterle A., Doherty J., Epperson CN., Deligiannidis KM., Riesenberg R., Hoffmann E., Rubinow D., Jonas J., Paul S., Meltzer-Brody S. 2017
Use of antidepressant medication in pregnancy and adverse neonatal outcomes: A population-based investigation. Cantarutti A., Merlino L., Giaquinto C., Corrao G. 2017
Lithium Use in Pregnancy and the Risk of Cardiac Malformations. Patorno E., Huybrechts KF., Bateman BT., Cohen JM., Desai RJ., Mogun H., Cohen LS., Hernandez-Diaz S. 2017
Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates. Yang A., Ciolino JD., Pinheiro E., Rasmussen-Torvik LJ., Sit DKY., Wisner KL. 2017
Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study. Man KKC., Chan EW., Ip P., Coghill D., Simonoff E., Chan PKL., Lau WCY., Schuemie MJ., Sturkenboom MCJM., Wong ICK. 2017
Autism risk following antidepressant medication during pregnancy. Viktorin A., Uher R., Reichenberg A., Levine SZ., Sandin S. 2017
Risk of postpartum episodes in women with bipolar disorder after lamotrigine or lithium use during pregnancy: A population-based cohort study. Wesseloo R., Liu X., Clark CT., Kushner SA., Munk-Olsen T., Bergink V. 2017
Pregnancy and postpartum antidepressant use moderates the effects of sleep on depression. Stone KC., Salisbury AL., Miller-Loncar CL., Mattera JA., Battle CL., Johnsen DM., O'Grady KE. 2017
The effects of gestational use of antidepressants and antipsychotics on neonatal outcomes for women with severe mental illness. Frayne J., Nguyen T., Bennett K., Allen S., Hauck Y., Liira H. 2017
Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort. Bérard A., Zhao JP., Sheehy O. 2017
Is the Risk of Preterm Birth and Low Birth Weight Affected by the Use of Antidepressant Agents during Pregnancy? A Population-Based Investigation. Cantarutti A., Merlino L., Monzani E., Giaquinto C., Corrao G. 2016
Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring. Brown AS., Gyllenberg D., Malm H., McKeague IW., Hinkka-Yli-Salomäki S., Artama M., Gissler M., Cheslack-Postava K., Weissman MM., Gingrich JA., Sourander A. 2016
Prenatal exposure to antidepressants and risk of epilepsy in childhood. Mao Y., Pedersen LH., Christensen J., Vestergaard M., Zhou W., Olsen J., Sun Y. 2016
Prenatal antidepressant exposure and child behavioural outcomes at 7 years of age: a study within the Danish National Birth Cohort. Grzeskowiak LE., Morrison JL., Henriksen TB., Bech BH., Obel C., Olsen J., Pedersen LH. 2016
Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age. Grzeskowiak LE., Gilbert AL., Sørensen TI., Olsen J., Sørensen HT., Pedersen LH., Morrison JL. 2013
Prenatal exposure to selective serotonin reuptake inhibitors and non-verbal cognitive functioning in childhood. El Marroun H., White TJ., Fernandez G., Jaddoe VW., Verhulst FC., Stricker BH., Tiemeier H. 2017
Selective serotonin reuptake inhibitors and autism: additional data on the Quebec Pregnancy/Birth Cohort. Bérard A., Boukhris T., Sheehy O. 2016
Risk of gestational hypertension and preeclampsia in women who discontinued or continued antidepressant medication use during pregnancy. De Ocampo MPG., Araneta MRG., Macera CA., Alcaraz JE., Moore TR., Chambers CD. 2016
Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study. Malm H., Brown AS., Gissler M., Gyllenberg D., Hinkka-Yli-Salomäki S., McKeague IW., Weissman M., Wickramaratne P., Artama M., Gingrich JA., Sourander A. 2016
Risk of Miscarriage in Women Receiving Antidepressants in Early Pregnancy, Correcting for Induced Abortions. Almeida ND., Basso O., Abrahamowicz M., Gagnon R., Tamblyn R. 2016
Preschool outcomes following prenatal serotonin reuptake inhibitor exposure: differences in language and behavior, but not cognitive function. Johnson KC., Smith AK., Stowe ZN., Newport DJ., Brennan PA. 2016
Behavior and inhibitory control in children with prenatal exposure to antidepressants and medically untreated depression. Hermansen TK., Røysamb E., Augusti EM., Melinder A. 2016
Depression, anxiety, and antidepressant treatment in women: association with in vitro fertilization outcome. Cesta CE., Viktorin A., Olsson H., Johansson V., Sjölander A., Bergh C., Skalkidou A., Nygren KG., Cnattingius S., Iliadou AN. 2016
The effect of antidepressants on fertility. Casilla-Lennon MM., Meltzer-Brody S., Steiner AZ. 2016
Antidepressant Use During Pregnancy and the Risk of Autism Spectrum Disorder in Children. Boukhris T., Sheehy O., Mottron L., Bérard A. 2016
The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month. Salisbury AL., O'Grady KE., Battle CL., Wisner KL., Anderson GM., Stroud LR., Miller-Loncar CL., Young ME., Lester BM. 2016
Pregnancy Complications Following Prenatal Exposure to SSRIs or Maternal Psychiatric Disorders: Results From Population-Based National Register Data. Malm H., Sourander A., Gissler M., Gyllenberg D., Hinkka-Yli-Salomäki S., McKeague IW., Artama M., Brown AS. 2015
Methodological considerations in assessing the effectiveness of antidepressant medication continuation during pregnancy using administrative data. Swanson SA., Hernandez-Diaz S., Palmsten K., Mogun H., Olfson M., Huybrechts KF. 2015
Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. Huybrechts KF., Bateman BT., Palmsten K., Desai RJ., Patorno E., Gopalakrishnan C., Levin R., Mogun H., Hernandez-Diaz S. 2015
Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study. Winterfeld U., Klinger G., Panchaud A., Stephens S., Arnon J., Malm H., Te Winkel B., Clementi M., Pistelli A., Maňáková E., Eleftheriou G., Merlob P., Kaplan YC., Buclin T., Rothuizen LE. 2015
Antidepressant medication use, depression, and the risk of preeclampsia. Avalos LA., Chen H., Li DK. 2015
Antidepressant use during pregnancy and asthma in the offspring. Liu X., Olsen J., Pedersen LH., Agerbo E., Yuan W., Li J. 2015
No association between prenatal exposure to psychotropics and intelligence at age five. Eriksen HL., Kesmodel US., Pedersen LH., Mortensen EL. 2015
Sertraline use during pregnancy and the risk of major malformations. Bérard A., Zhao JP., Sheehy O. 2015
Treatment of postnatal depression with cognitive behavioural therapy, sertraline and combination therapy: a randomised controlled trial. Milgrom J., Gemmill AW., Ericksen J., Burrows G., Buist A., Reece J. 2015
Maternal use of selective serotonin reuptake inhibitors and risk of miscarriage - assessing potential biases. Johansen RL., Mortensen LH., Andersen AM., Hansen AV., Strandberg-Larsen K. 2015
Impact of prenatal exposure to serotonin reuptake inhibitors or maternal major depressive disorder on infant developmental outcomes. Santucci AK., Singer LT., Wisniewski SR., Luther JF., Eng HF., Dills JL., Sit DK., Hanusa BH., Wisner KL. 2014
First trimester exposure to anxiolytic and hypnotic drugs and the risks of major congenital anomalies: a United Kingdom population-based cohort study. Ban L., West J., Gibson JE., Fiaschi L., Sokal R., Doyle P., Hubbard R., Smeeth L., Tata LJ. 2014
Antidepressant use in pregnancy and the risk of cardiac defects. Huybrechts KF., Palmsten K., Avorn J., Cohen LS., Holmes LB., Franklin JM., Mogun H., Levin R., Kowal M., Setoguchi S., Hernández-Díaz S. 2014
Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study. Diav-Citrin O., Shechtman S., Tahover E., Finkel-Pekarsky V., Arnon J., Kennedy D., Erebara A., Einarson A., Ornoy A. 2014
Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study. Ban L., Gibson JE., West J., Fiaschi L., Sokal R., Smeeth L., Doyle P., Hubbard RB., Tata LJ. 2014
Birth weight and preterm birth in babies of pregnant women with major depression in relation to treatment with antidepressants. Şahingöz M., Yuksel G., Karsidag C., Uguz F., Sonmez EO., Annagur BB., Annagur A. 2014
Effects of maternal psychotropic drug dosage on birth outcomes. Michielsen LA., van der Heijden FM., Janssen PK., Kuijpers HJ. 2014
Perinatal outcomes of pregnancies complicated by maternal depression with or without selective serotonin reuptake inhibitor therapy. Engelstad HJ., Roghair RD., Calarge CA., Colaizy TT., Stuart S., Haskell SE. 2014
Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism. Hviid A., Melbye M., Pasternak B. 2013
Antidepressant exposure in pregnancy and risk of autism spectrum disorders. Sørensen MJ., Grønborg TK., Christensen J., Parner ET., Vestergaard M., Schendel D., Pedersen LH. 2013
A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression. Hantsoo L., Ward-O'Brien D., Czarkowski KA., Gueorguieva R., Price LH., Epperson CN. 2014
Risk of vaginal bleeding and postpartum hemorrhage after use of antidepressants in pregnancy: a study from the Norwegian Mother and Child Cohort Study. Lupattelli A., Spigset O., Koren G., Nordeng H. 2014
Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States. Palmsten K., Hernández-Díaz S., Huybrechts KF., Williams PL., Michels KB., Achtyes ED., Mogun H., Setoguchi S. 2013
Antidepressant use and risk for preeclampsia. Palmsten K., Huybrechts KF., Michels KB., Williams PL., Mogun H., Setoguchi S., Hernández-Díaz S. 2013
Does fetal exposure to SSRIs or maternal depression impact infant growth? Wisner KL., Bogen DL., Sit D., McShea M., Hughes C., Rizzo D., Confer A., Luther J., Eng H., Wisniewski SW. 2013
Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Nulman I., Koren G., Rovet J., Barrera M., Pulver A., Streiner D., Feldman B. 2012
Prenatal antidepressant exposure and behavioral problems in early childhood--a cohort study. Pedersen LH., Henriksen TB., Bech BH., Licht RW., Kjaer D., Olsen J. 2013
Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception. Weikum WM., Oberlander TF., Hensch TK., Werker JF. 2012
Live and non-live pregnancy outcomes among women with depression and anxiety: a population-based study. Ban L., Tata LJ., West J., Fiaschi L., Gibson JE. 2012
Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors. Grzeskowiak LE., Gilbert AL., Morrison JL. 2012
Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies. Hayes RM., Wu P., Shelton RC., Cooper WO., Dupont WD., Mitchel E., Hartert TV. 2012
Prenatal antipsychotic exposure and neuromotor performance during infancy. Johnson KC., LaPrairie JL., Brennan PA., Stowe ZN., Newport DJ. 2012
Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants? Palmsten K., Setoguchi S., Margulis AV., Patrick AR., Hernández-Díaz S. 2012
Affect Expression and Self-Regulation Capacities of Infants Exposed in utero to Psychotropics. Reebye PN., Ng TW., Misri S., Stikarovska I. 2012
The effect of sertraline add-on to brief dynamic psychotherapy for the treatment of postpartum depression: a randomized, double-blind, placebo-controlled study. Bloch M., Meiboom H., Lorberblatt M., Bluvstein I., Aharonov I., Schreiber S. 2012
Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study. Klieger-Grossmann C., Weitzner B., Panchaud A., Pistelli A., Einarson T., Koren G., Einarson A. 2012
Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment. Salisbury AL., Wisner KL., Pearlstein T., Battle CL., Stroud L., Lester BM. 2011
A prospective, naturalistic, blinded study of early neurobehavioral outcomes for infants following prenatal antidepressant exposure. Suri R., Hellemann G., Stowe ZN., Cohen LS., Aquino A., Altshuler LL. 2011
Association between antidepressant use during pregnancy and infants born small for gestational age. Ramos É., St-André M., Bérard A. 2010
Use of antidepressants during pregnancy and the risk of spontaneous abortion. Nakhai-Pour HR., Broy P., Bérard A. 2010
Antidepressant use during pregnancy and the risk of preterm delivery and fetal growth restriction. Toh S., Mitchell AA., Louik C., Werler MM., Chambers CD., Hernández-Díaz S. 2009
Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference? Lin HC., Chen IJ., Chen YH., Lee HC., Wu FJ. 2010
Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. Pedersen LH., Henriksen TB., Vestergaard M., Olsen J., Bech BH. 2009
Placental transfer of SSRI and SNRI antidepressants and effects on the neonate. Rampono J., Simmer K., Ilett KF., Hackett LP., Doherty DA., Elliot R., Kok CH., Coenen A., Forman T. 2009
Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Wisner KL., Sit DK., Hanusa BH., Moses-Kolko EL., Bogen DL., Hunker DF., Perel JM., Jones-Ivy S., Bodnar LM., Singer LT. 2009
Sexual function in postpartum women treated for depression: results from a randomized trial of nortriptyline versus sertraline. Lanza di Scalea T., Hanusa BH., Wisner KL. 2009
Postpartum depression: a randomized trial of sertraline versus nortriptyline. Wisner KL., Hanusa BH., Perel JM., Peindl KS., Piontek CM., Sit DK., Findling RL., Moses-Kolko EL. 2006
Serotonin reuptake inhibitor use in pregnancy and the neonatal behavioral syndrome. Jordan AE., Jackson GL., Deardorff D., Shivakumar G., McIntire DD., Dashe JS. 2008
Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study. Newham JJ., Thomas SH., MacRitchie K., McElhatton PR., McAllister-Williams RH. 2008
Lamotrigine in bipolar disorder: efficacy during pregnancy. Newport DJ., Stowe ZN., Viguera AC., Calamaras MR., Juric S., Knight B., Pennell PB., Baldessarini RJ. 2008
Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine. Yonkers KA., Lin H., Howell HB., Heath AC., Cohen LS. 2008
Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Viguera AC., Whitfield T., Baldessarini RJ., Newport DJ., Stowe Z., Reminick A., Zurick A., Cohen LS. 2007
Birth outcomes following prenatal exposure to antidepressants. Pearson KH., Nonacs RM., Viguera AC., Heller VL., Petrillo LF., Brandes M., Hennen J., Cohen LS. 2007
Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Davis RL., Rubanowice D., McPhillips H., Raebel MA., Andrade SE., Smith D., Yood MU., Platt R. 2007
Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. Newport DJ., Calamaras MR., DeVane CL., Donovan J., Beach AJ., Winn S., Knight BT., Gibson BB., Viguera AC., Owens MJ., Nemeroff CB., Stowe ZN. 2007
Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Suri R., Altshuler L., Hellemann G., Burt VK., Aquino A., Mintz J. 2007
First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. Bérard A., Ramos E., Rey E., Blais L., St-André M., Oraichi D. 2007
Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes. Djulus J., Koren G., Einarson TR., Wilton L., Shakir S., Diav-Citrin O., Kennedy D., Voyer Lavigne S., De Santis M., Einarson A. 2006
Patient choice of treatment for postpartum depression: a pilot study. Pearlstein TB., Zlotnick C., Battle CL., Stuart S., O'Hara MW., Price AB., Grause MA., Howard M. 2006
Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Oberlander TF., Warburton W., Misri S., Aghajanian J., Hertzman C. 2006
Olanzapine in the prevention of postpartum psychosis and mood episodes in bipolar disorder. Sharma V., Smith A., Mazmanian D. 2006
Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. Misri S., Reebye P., Kendrick K., Carter D., Ryan D., Grunau RE., Oberlander TF. 2006
Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. Cohen LS., Altshuler LL., Harlow BL., Nonacs R., Newport DJ., Viguera AC., Suri R., Burt VK., Hendrick V., Reminick AM., Loughead A., Vitonis AF., Stowe ZN. 2006
Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome. Sivojelezova A., Shuhaiber S., Sarkissian L., Einarson A., Koren G. 2005
Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Chun-Fai-Chan B., Koren G., Fayez I., Kalra S., Voyer-Lavigne S., Boshier A., Shakir S., Einarson A. 2005
Prevention of postpartum episodes in women with bipolar disorder. Wisner KL., Hanusa BH., Peindl KS., Perel JM. 2004
The impact of depression and fluoxetine treatment on obstetrical outcome. Suri R., Altshuler L., Hendrick V., Rasgon N., Lee E., Mintz J. 2004
Neonate characteristics after maternal use of antidepressants in late pregnancy. Källén B. 2004
Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. Oberlander TF., Misri S., Fitzgerald CE., Kostaras X., Rurak D., Riggs W. 2004
Frequency of infant adverse events that are associated with citalopram use during breast-feeding. Lee A., Woo J., Ito S. 2004
Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. Casper RC., Fleisher BE., Lee-Ancajas JC., Gilles A., Gaylor E., DeBattista A., Hoyme HE. 2003
Outcomes of prenatal antidepressant exposure. Simon GE., Cunningham ML., Davis RL. 2002
Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Nulman I., Rovet J., Stewart DE., Wolpin J., Pace-Asciak P., Shuhaiber S., Koren G. 2002
Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study. Einarson A., Fatoye B., Sarkar M., Lavigne SV., Brochu J., Chambers C., Mastroiacovo P., Addis A., Matsui D., Schuler L., Einarson TR., Koren G. 2001
Outcome of children exposed in utero to fluoxetine: a critical review. Koren G., Nulman I., Addis A. 1998
Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac) Pastuszak A., Schick-Boschetto B., Zuber C., Feldkamp M., Pinelli M., Sihn S., Donnenfeld A., McCormack M., Leen-Mitchell M., Woodland C. 1993
A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. Appleby L., Warner R., Whitton A., Faragher B. 1997
Neurodevelopment of children exposed in utero to antidepressant drugs. Nulman I., Rovet J., Stewart DE., Wolpin J., Gardner HA., Theis JG., Kulin N., Koren G. 1997
Association of maternal lithium exposure and premature delivery. Troyer WA., Pereira GR., Lannon RA., Belik J., Yoder MC. -- Not Found --
Lithium and pregnancy. A cohort study on manic-depressive women. Källén B., Tandberg A. 1983
Hydroxyzine for controlling postpartum anxiety: a double-blind study. Reisner JG. 1967
One-Year Developmental Outcomes for Infants of Mothers With Bipolar Disorder. Santucci AK., Singer LT., Wisniewski SR., Luther JF., Eng HF., Sit DK., Wisner KL. -- Not Found --
Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes. Park Y., Hernandez-Diaz S., Bateman BT., Cohen JM., Desai RJ., Patorno E., Glynn RJ., Cohen LS., Mogun H., Huybrechts KF. 2018
Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study. Sadowski A., Todorow M., Yazdani Brojeni P., Koren G., Nulman I. 2013
Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study. Jimenez-Solem E., Andersen JT., Petersen M., Broedbaek K., Jensen JK., Afzal S., Gislason GH., Torp-Pedersen C., Poulsen HE. 2012
Birth weight and use of olanzapine in pregnancy: a prospective comparative study. Babu GN., Desai G., Tippeswamy H., Chandra PS. 2010
Risks associated with antipsychotic treatment in pregnancy: Comparative cohort studies based on electronic health records. Petersen I., Sammon CJ., McCrea RL., Osborn DPJ., Evans SJ., Cowen PJ., Nazareth I. 2016
Zolpidem (Ambien) in pregnancy: placental passage and outcome. Juric S., Newport DJ., Ritchie JC., Galanti M., Stowe ZN. 2009
Duration of antidepressant use during pregnancy and risk of major congenital malformations. Ramos E., St-André M., Rey E., Oraichi D., Bérard A. 2008
Bipolar disorder and psychotropic medication: Impact on pregnancy and neonatal outcomes. Wisner KL., Sit D., O'Shea K., Bogen DL., Clark CT., Pinheiro E., Yang A., Ciolino JD. 2019
Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations. Huybrechts KF., Hernández-Díaz S., Patorno E., Desai RJ., Mogun H., Dejene SZ., Cohen JM., Panchaud A., Cohen L., Bateman BT. 2016
Risk of adverse perinatal outcomes among women with pharmacologically treated and untreated depression during pregnancy: A retrospective cohort study. Adhikari K., Patten SB., Lee S., Metcalfe A. 2019
Risk of Congenital Heart Disease in Newborns with Prenatal Exposure to Anti-depressant Medications. Desai PH., Yagnik PJ., Ross Ascuitto N., Prajapati P., Sernich S. 2019
The association between gestational diabetes mellitus, antipsychotics and severe mental illness in pregnancy: A multicentre study. Galbally M., Frayne J., Watson SJ., Morgan V., Snellen M. 2020
Association of Maternal Use of Benzodiazepines and Z-Hypnotics During Pregnancy With Motor and Communication Skills and Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers. Lupattelli A., Chambers CD., Bandoli G., Handal M., Skurtveit S., Nordeng H. 2019
Patterns of prenatal antidepressant exposure and risk of preeclampsia and postpartum haemorrhage. Palmsten K., Chambers CD., Wells A., Bandoli G. 2020
Pregnancy outcomes following maternal venlafaxine use: A prospective observational comparative cohort study. Richardson JL., Martin F., Dunstan H., Greenall A., Stephens S., Yates LM., Thomas SHL. 2019
In Utero Antidepressants and Neurodevelopmental Outcomes in Kindergarteners. Singal D., Chateau D., Struck S., Lee JB., Dahl M., Derksen S., Katz LY., Ruth C., Hanlon-Dearman A., Brownell M. 2020
Obstetric complications in bipolar disorder: Psychiatric factors and the risk of caesarean section. Solé E., Roca A., Torres A., Hernández AS., Fernández N., Díaz CN., Vieta E., Garcia-Esteve L. 2020
Pregnancy hypertension and its associations with pre-pregnancy depression, anxiety, antidepressants, and anxiolytics. Thombre Kulkarni M., Holzman C., Wasilevich E., Luo Z., Scheid J., Allswede M. 2019
Antidepressant Use around Conception, Prepregnancy Depression, and Risk of Ectopic Pregnancy. Wall-Wieler E., Robakis TK., Cesta CE., Masarwa R., Lyell DJ., Liu C., Platt RW., Carmichael SL. 2020
Benzodiazepine use before conception and risk of ectopic pregnancy. Wall-Wieler E., Robakis TK., Lyell DJ., Masarwa R., Platt RW., Carmichael SL. 2020
Antidepressant continuation in pregnancy and risk of gestational diabetes. Wartko PD., Weiss NS., Enquobahrie DA., Chan KCG., Stephenson-Famy A., Mueller BA., Dublin S. 2019
Association between antidepressant use during pregnancy and autism spectrum disorder in children: a retrospective cohort study based on Japanese claims data. Yamamoto-Sasaki M., Yoshida S., Takeuchi M., Tanaka-Mizuno S., Ogawa Y., Furukawa TA., Kawakami K. 2019
The mother, the infant and the mother-infant relationship: What is the impact of antidepressant medication in pregnancy. Galbally M., Watson SJ., Boyce P., Nguyen T., Lewis AJ. 2020
Impact of antidepressant use, discontinuation, and dosage modification on maternal depression during pregnancy. Bérard A., Sheehy O., Zhao JP., Chambers C., Roth M., Bozzo P., Johnson D., Kao K., Lavigne S., Wolfe L., Quinn D., Dieter K. 2019
Anticonvulsant Mood Stabilizer and Lithium Use and Risk of Adverse Pregnancy Outcomes. Cohen JM., Huybrechts KF., Patorno E., Desai RJ., Mogun H., Bateman BT., Hernández-Díaz S. 2019
The effect of antenatal depression and antidepressant treatment on placental tissue: a protein-validated gene expression study. Edvinsson Å., Hellgren C., Kunovac Kallak T., Åkerud H., Skalkidou A., Stener-Victorin E., Fornes R., Spigset O., Lager S., Olivier J., Sundström-Poromaa I. 2019
Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study. Huybrechts KF., Bateman BT., Pawar A., Bessette LG., Mogun H., Levin R., Li H., Motsko S., Scantamburlo Fernandes MF., Upadhyaya HP., Hernandez-Diaz S. 2020
Analysis of Perinatal Women Attending a Mother and Baby Unit Taking Sodium Valproate or Lithium with a Diagnosis of Bipolar Affective Disorder. Lebedevs T., Gan M., Teoh SWK., Brown P. 2020
The effect of maternal antidepressants on third trimester uteroplacental hemodynamics and the neonatal abstinence syndrome: a retrospective cohort study. McLean K., Murphy KE., Dalfen A., Shea AK. 2019
Postpartum Bleeding in Pregnant Women Receiving SSRIs/SNRIs: New Insights From a Descriptive Observational Study and an Analysis of Data from the FAERS Database. Perrotta C., Giordano F., Colombo A., Carnovale C., Castiglioni M., Di Bernardo I., Giorgetti F., Pileri P., Clementi E., Viganò C. 2019
Trajectories of antipsychotic use before and during pregnancy and associated maternal and birth characteristics. Schaffer AL., Zoega H., Tran DT., Buckley NA., Pearson S., Havard A. 2019
Association Between Incident Exposure to Benzodiazepines in Early Pregnancy and Risk of Spontaneous Abortion. Sheehy O., Zhao JP., Bérard A. 2019
Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects. Anderson KN., Lind JN., Simeone RM., Bobo WV., Mitchell AA., Riehle-Colarusso T., Polen KN., Reefhuis J. 2020
Bupropion in pregnancy and the prevalence of congenital malformations. Cole JA., Modell JG., Haight BR., Cosmatos IS., Stoler JM., Walker AM. 2007
Comparison of the groups treated with mirtazapine and selective serotonine reuptake inhibitors with respect to birth outcomes and severity of psychiatric disorder Güngör, B. B. Öztürk, N. Atar, A. Ö Aydın, N. 2019

Creative Commons LicenseThis graphic notice indicates that you are leaving this Federal Government Web site and entering a non-Federal Web site. Creative Commons  
The data contained in this project are distributed under the terms of the Creative Commons Attribution-NonCommerical license, which permits the use, dissemination, and reproduction in any medium, provided the original work is properly cited, and that the use is non-commercial and otherwise in compliance with the license. See: